Q4 2022 Holdings
Filed 2023-02-10 | 40 holdings | $287.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harrow Health Inc(HROW) | COM | 415858109 | $55.7M | 3,775,000 | 19.4% |
| Tela BIO Inc(TELA) | COM | 872381108 | $23.8M | 2,072,813 | 8.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $21.4M | 735,000 | 7.4% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $17.1M | 6,075,000 | 5.9% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $13.4M | 732,000 | 4.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $11.5M | 250,000 | 4.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $11.4M | 238,000 | 4.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.5M | 177,000 | 3.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $7.5M | 540,000 | 2.6% |
| 4D Molecular Therapeutics Inc(FDMT) | COM | 35104E100 | $7.3M | 330,000 | 2.5% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $7.2M | 2,692,594 | 2.5% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $6.8M | 4,590,000 | 2.4% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $6.4M | 1,560,000 | 2.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $6.2M | 923,200 | 2.2% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $6.1M | 2,170,000 | 2.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $5.5M | 611,400 | 1.9% |
| Proqr Therapeutics NV | SHS EURO | N71542109 | $5.4M | 1,460,000 | 1.9% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $4.7M | 417,500 | 1.6% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $4.5M | 243,000 | 1.6% |
| Codexis Inc(CDXS) | COM | 192005106 | $4.5M | 957,500 | 1.6% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $4.3M | 488,656 | 1.5% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $4.3M | 1,206,841 | 1.5% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $3.9M | 261,703 | 1.4% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $3.6M | 560,000 | 1.2% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $3.4M | 167,500 | 1.2% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $3.3M | 826,200 | 1.1% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $3.3M | 306,713 | 1.1% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $3.2M | 252,046 | 1.1% |
| Morphosys AG | SPONSORED ADS | 617760202 | $3.2M | 896,600 | 1.1% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.7M | 460,000 | 0.9% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $2.7M | 535,000 | 0.9% |
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $2.6M | 272,200 | 0.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $2.5M | 138,800 | 0.9% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $2.5M | 1,185,000 | 0.9% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $2.2M | 261,800 | 0.8% |
| Fortress Biotech Inc | COM | 34960Q109 | $1.3M | 2,050,000 | 0.5% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $1.3M | 153,500 | 0.4% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $982.9K | 87,600 | 0.3% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $936.1K | 485,000 | 0.3% |
| Modular Medical Inc(MODD) | COM NEW | 60785L207 | $490.0K | 245,000 | 0.2% |